期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 405, 期 1-3, 页码 329-339出版社
ELSEVIER
DOI: 10.1016/S0014-2999(00)00563-X
关键词
dopamine transporter; cocaine; cocaine analog; phosphorylation; chimera; site-directed mutagenesis
资金
- NIDA NIH HHS [DA08379, DA11978] Funding Source: Medline
The dopamine transporter mediates uptake of dopamine into neurons and is a major target for various pharmacologically active drugs and environmental toxins. Since its cloning, much information has been obtained regarding its structure and function. Binding domains for dopamine and various blocking drugs including cocaine an likely formed by interactions with multiple amino acid residues, some of which are separate in the primary structure but lie close together in the still unknown tertiary structure. Chimera and site-directed mutagenesis studies suggest the involvement of both overlapping and separate domains in the interaction with substrates and blockers, whereas recent findings with involvement of both overlapping and separate domains in the interaction with substrates nad blockers, binding of blockers such as cocaine. The dopamine transporter can also operate in reverse, i.e. in an efflux mode, and recent mutagenesis experiments show different structural requirements for inward and outward transport. Strong evidence for dopamine transporter domains selectively influencing binding of dopamine or cocaine analogs has not yet emerged, although the development of a cocaine antagonist at the level of the transporter remains a possibility. (C) 2000 Elsevier Science B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据